36 results found.

Glaucoma, or Glaucoma, Open Angle Clinical Trial using AqueSys XEN 45 Glaucoma Implant

AqueSys, Inc. - Recruiting 45 years or older.
- A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects With Refractory Glaucoma.
AqueSys XEN 45 Glaucoma Implant

Glaucoma Clinical Trial using Ripcord removal

Duke University - Recruiting 18 years or older.
- The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants.
Ripcord removal

Open Angle Glaucoma, or Ocular Hypertension Clinical Trial using PG324 Ophthalmic Solution, 0.01%; PG324 Ophthalmic Solution, 0.02%; AR-13324 Ophthalmic Solution, 0.02%; Latanoprost Ophthalmic Solution, 0.005%

Aerie Pharmaceuticals - Recruiting 18 years or older.
- A Double-masked, Randomized, Controlled Study Assessing the Safety and Ocular Hypotensive Efficacy of PG324 Ophthalmic Solution, 0.01% and PG324 Ophthalmic Solution, 0.02%, Compared to AR-13324 Ophthalmic Solution, 0.02% and Latanoprost Ophthalmic Solution, 0.005% in Patients With Elevated Intraocular Pressure.
PG324 Ophthalmic Solution, 0.01%; PG324 Ophthalmic Solution, 0.02%; AR-13324 Ophthalmic Solution, 0.02%; Latanoprost Ophthalmic Solution, 0.005%

Glaucoma, or Ocular Hypertension Clinical Trial using bimatoprost 0.01% ophthalmic solution; bimatoprost 0.03% ophthalmic solution

Allergan - Recruiting 18 years or older.
- .
bimatoprost 0.01% ophthalmic solution; bimatoprost 0.03% ophthalmic solution

Glaucoma, Angle-closure, Primary, Acute Clinical Trial using QPI-1007 Injection; (including placebo)

Quark Pharmaceuticals - Recruiting 40 years or older.
- Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG).
QPI-1007 Injection; (including placebo)

Normal Eyes, Eyes With Glaucoma, or Eyes With Retinal Disease Clinical Trial

Topcon Medical Systems, Inc. - Recruiting 18 years or older.
- Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Agreement and Precision Study.

Ocular Hypertension, or Open-Angle Glaucoma Clinical Trial using Latanoprost Punctal Plug Delivery System (L-PPDS); Timolol Maleate GFS, 0.5%

Mati Therapeutics Inc. - Recruiting 18 years or older.
- A Phase 2 Single-Masked, Randomized, Parallel Comparison of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Timolol Maleate Ophthalmic Gel Forming Solution 0.5% in Subjects With Ocular Hypertension or Open-Angle Glaucoma.
Latanoprost Punctal Plug Delivery System (L-PPDS); Timolol Maleate GFS, 0.5%

Glaucoma, or Ocular Hypertension Clinical Trial using bimatoprost 0.01%; travatan 0.004%; timolol 0.5%; hypromellose 0.3%

Allergan - Recruiting 18 years or older.
- .
bimatoprost 0.01%; travatan 0.004%; timolol 0.5%; hypromellose 0.3%

Glaucoma Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 4 years or older.
- Clinical and Molecular Studies in Families With Glaucoma and Related Diseases.

Primary Open Angle Glaucoma Clinical Trial using XEN Gel Stent; XEN Gel Stent with cataract surgery

AqueSys, Inc. - Recruiting 18 years or older.
- .
XEN Gel Stent; XEN Gel Stent with cataract surgery

Glaucoma, or Ocular Hypertension Clinical Trial using Bimatoprost 0.01%; Bimatoprost 0.03%

Allergan - Recruiting 18 years or older.
- .
Bimatoprost 0.01%; Bimatoprost 0.03%

Choroidal Neovascularization, Macular Edema, Glaucoma, Neovascula Clinical Trial using ranibizumab

Novartis - Recruiting 18 years or older.
- An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases..
ranibizumab

Open Angle Glaucoma, or Ocular Hypertension Clinical Trial using Beta-blocker monotherapy; Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution

Alcon Research - Recruiting 18 years or older.
- Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTravr in Patients Previously Uncontrolled on a Beta-blocker.
Beta-blocker monotherapy; Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution

Glaucoma, or Quality of Life Clinical Trial

Wills Eye - Recruiting 18 years to 80 years.
- A Prospective, Longitudinal, Observational Cohort Study Examining How Glaucoma Affects Quality of Life and Visual Function Over a 4-Year Period.

Glaucoma Clinical Trial

Wills Eye - Recruiting 18 years or older.
- Validation and Reproducibility of Spaeth/Richman Contrast Sensitivity Test.

Ocular Hypertension Clinical Trial using Sensimed Triggersfishr

Sensimed AG - Recruiting 18 years or older.
- A Single-center, Open Label, Prospective Study Assessing the 24-hour IOP Patterns Using SENSIMED Triggerfishr in Ocular Hypertensive Patients Newly Converted to Glaucomatous Disease Versus Stable Ocular Hypertensive Patients.
Sensimed Triggersfishr

Open Angle Glaucoma Clinical Trial using Acular LS; Pred Forte; Refresh Tears

University of Colorado, Denver - Recruiting 18 years or older.
- A Randomized Prospective Double Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells..
Acular LS; Pred Forte; Refresh Tears

Primary Open Angle Glaucoma Clinical Trial

Vasan Eye Care Hospital - Recruiting 18 years to 75 years.
- A Cross Sectional Study of Correlation Between Retinal Nerve Fibre Thickness Measured by Optical Coherence Tomography and Humphrey Visual Fields in Early and Moderate Open Angle Glaucoma.

Open-Angle Glaucoma Clinical Trial using iStent and iStent supra

Glaukos Corporation - Recruiting 18 years or older.
- A Prospective Evaluation of Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin.
iStent and iStent supra

Primary Open-angle Glaucoma Clinical Trial using iStent inject; Cataract surgery

Glaukos Corporation - Recruiting 45 years or older.
- A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukosr Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery.
iStent inject; Cataract surgery

Ocular Hypertension, or Primary Open Angle Glaucoma Clinical Trial using VISION5 Product

ForSight Vision5, Inc. - Recruiting 18 years or older.
- A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension.
VISION5 Product

Open-Angle Glaucoma, or Ocular Hypertension Clinical Trial using Brinzolamide 1 %/Brimonidine 0.2% ophthalmic suspension; Timolol Maleate 0.5%

Alcon Research - Recruiting 18 years or older.
- Prospective, Randomized, Single-Center Study to Evaluate 24-hour Intraocular Pressure Control With Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination Therapy.
Brinzolamide 1 %/Brimonidine 0.2% ophthalmic suspension; Timolol Maleate 0.5%

Glaucoma Clinical Trial using Prednisolone 1%; Diclofenac 0.1%; Artificial Tears

University of Miami - Recruiting 18 years or older.
- Steroids And Laser Trabeculoplasty (SALT) Trial: Effect of Anti-Inflammatory Treatment on the Efficacy of SLT.
Prednisolone 1%; Diclofenac 0.1%; Artificial Tears

Glaucoma Clinical Trial using Practice program

Oftalmologia Hospital Sotero del Rio - Recruiting 18 years or older.
- Effect of Exposure to Computer Simulated Visual Field Testing on Variability and Reliability of Test Results: A Randomized Controlled Trial.
Practice program

Glaucomas, or Pterygium Clinical Trial using ologenT Collagen matrix implantation in glaucoma filtering surgery

Pro Top & Mediking Company Limited - Recruiting 18 years or older.
- Study of the Safety and Effectiveness of the Ologen(OculusGen) Collagen Matrix Implant as an Aid in Glaucoma and Pterygium Surgery.
ologenT Collagen matrix implantation in glaucoma filtering surgery

Open-angle Glaucoma Clinical Trial using Use of ologen Collagen Matrix in trabeculectomy; Use of Mitomycin-C in trabeculectomy

Aeon Astron Europe B.V. - Recruiting 18 years or older.
- A Prospective Randomized Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy.
Use of ologen Collagen Matrix in trabeculectomy; Use of Mitomycin-C in trabeculectomy

Glaucoma Clinical Trial using Omeprazole; Placebo

Shahid Beheshti Medical University - Recruiting 18 years to 70 years.
- Evaluation of Omeprazole Effect on Glaucoma.
Omeprazole; Placebo

Primary Congenital Glaucoma Clinical Trial

Samsung Medical Center - Recruiting N/A or older.
- Study of Gene, Inheritance Pattern and Genotype - Phenotype Correlations in South Korean Patients With Primary Congenital Glaucoma.

Glaucoma Clinical Trial using pattern scanning laser iridotomy and iridoplasty

National University Hospital, Singapore - Recruiting 21 years to 80 years.
- Prospective Evaluation of the Efficacy of Pascal Laser Iridotomy and Pascal Laser Peripheral Iridoplasty: A Pilot Study.
pattern scanning laser iridotomy and iridoplasty

Open Angle Glaucoma, or Ocular Hypertension Clinical Trial using laser trabeculoplasty

Santa Clara Valley Health & Hospital System - Recruiting 18 years or older.
- Prospective Evaluation of the Efficacy of Pascal Trabeculoplasty: A Pilot Study.
laser trabeculoplasty

Refractory Glaucoma Clinical Trial using Ahmed Glaucoma Valve (AGV); Mitomycin C (MMC); amniotic membrane coverage

Shahid Beheshti Medical University - Recruiting 7 years to 75 years.
- Ahmed Glaucoma Valve Alone,With Amniotic Membrane or With MMC for Treatment of Refractory Glaucoma.
Ahmed Glaucoma Valve (AGV); Mitomycin C (MMC); amniotic membrane coverage

Glaucoma, or Myopia Clinical Trial

Yonsei University - Recruiting 18 years to 70 years.
- Corrected Measurement of the Retinal Nerve Fiber Layer Thickness by Optic Disc Configuration With the Cirrus HD OCT.

Cataract, or Glaucoma Clinical Trial using ologenT Collagen Matrix Implant as an aid in phacotrabeculectomy surgery

Pro Top & Mediking Company Limited - Recruiting 18 years or older.
- Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study.
ologenT Collagen Matrix Implant as an aid in phacotrabeculectomy surgery

Glaucoma, or Ocular Hypertension Clinical Trial using brimonidine 0.1%; Apraclonidine 0.5%

Walter Reed Army Medical Center - Recruiting 18 years or older.
- Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty.
brimonidine 0.1%; Apraclonidine 0.5%